Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 2
2014 1
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hankin j[au] (215 results)?
Delamanid in the treatment of multidrug-resistant tuberculosis.
Gupta R, Wells CD, Hittel N, Hafkin J, Geiter LJ. Gupta R, et al. Among authors: hafkin j. Int J Tuberc Lung Dis. 2016 Dec 1;20(12):33-37. doi: 10.5588/ijtld.16.0125. Int J Tuberc Lung Dis. 2016. PMID: 28240570 Review.
Infections in lung transplantation: new insights.
Hafkin J, Blumberg E. Hafkin J, et al. Curr Opin Organ Transplant. 2009 Oct;14(5):483-7. doi: 10.1097/MOT.0b013e32833062f6. Curr Opin Organ Transplant. 2009. PMID: 19623072 Review.
Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832.
Dawson R, Diacon AH, Narunsky K, De Jager VR, Stinson KW, Zhang X, Liu Y, Hafkin J. Dawson R, et al. Among authors: hafkin j. Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0147722. doi: 10.1128/aac.01477-22. Epub 2023 May 23. Antimicrob Agents Chemother. 2023. PMID: 37219453 Free PMC article. Clinical Trial.
Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.
Garcia-Prats AJ, Frias M, van der Laan L, De Leon A, Gler MT, Schaaf HS, Hesseling AC, Malikaarjun S, Hafkin J. Garcia-Prats AJ, et al. Among authors: hafkin j. Antimicrob Agents Chemother. 2022 May 17;66(5):e0214421. doi: 10.1128/aac.02144-21. Epub 2022 Apr 11. Antimicrob Agents Chemother. 2022. PMID: 35404075 Free PMC article. Clinical Trial.
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.
Mallikaarjun S, Chapagain ML, Sasaki T, Hariguchi N, Deshpande D, Srivastava S, Berg A, Hirota K, Inoue Y, Matsumoto M, Hafkin J, Geiter L, Wang X, Gumbo T, Liu Y. Mallikaarjun S, et al. Among authors: hafkin j. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01207-20. doi: 10.1128/AAC.01207-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33106263 Free PMC article.
16 results